# Holifya s.r.l.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/holifya-s-r-l

- Industry: Healthcare IT
- Headquarters: Milan, Italy
- Website: www.holifya.com
- Total disclosed funding: $1.9M
- Latest round: Series A (Sep 1, 2026)
- Investors on record: 6

## About

Based in Italy and founded in 2021 by CEO Alessandra Cestaro and CPO Marco Brustia, Holifya S.r.l. operates as a digital health company that offers personalized nutrition and prevention solutions based on analytics of genetic data and medical history. In September 2026, Holifya raised EUR 1.6 million in Series A led by Next Age, with participation from CDP Venture Capital, Doorway Capital, Zooga VC, 20Fund and Growth Engine. The round was part of a larger EUR 2 million equity, grant and debt funding.

Holifya S.r.l. offers an advanced check-up platform, personalized nutrition, and preventive medicine plans based on genetic profiles, blood chemistry biomarkers, habits, and goals. The company offers DNA diet testing, DNA intolerance testing, sports DNA testing, DNA skins testing, and comprehensive DNA testing for intolerances and sensitivities, metabolism and nutrition, sport, skin aging, and stress management. Furthermore, the company provides video consultations with the doctor.

Holifya primarily generates revenue through medical weight-management program fees paid by patients who enroll in its structured obesity treatment pathways. Additional revenue is derived from telemedicine consultations, specialist assessments, follow-up appointments, nutrition counseling, and ongoing clinical monitoring services. The company likely earns recurring revenue through subscription-based or membership-style medical programs that provide continuous support from physicians, nutritionists, and healthcare professionals. Further revenue opportunities may include care coordination services, digital health platform access, partner pharmacy collaborations, and medically supervised GLP-1/GIP treatment management services. Its core revenue driver is the sale of comprehensive, physician-led weight-loss and metabolic health programs delivered through a digital care model.

The company plans to utilize the September 2026 funding to strengthen its AI, consumer growth, partnerships in Italy, and clinical team.

## Funding rounds

- Series A, Sep 1, 2026, $1.9M — CDP Venture Capital, Doorway Capital, Growth Engine, Zooga VC, 20Fund, Next Age

## Investors

- CDP Venture Capital (https://capitalatlas.ai/funds/cdp-venture-capital) — Series A
- Doorway Capital (https://capitalatlas.ai/funds/doorway-capital) — Series A
- Growth Engine (https://capitalatlas.ai/funds/growth-engine) — Series A
- Zooga VC (https://capitalatlas.ai/funds/zooga-vc) — Series A
- 20Fund (https://capitalatlas.ai/funds/20fund) — Series A
- Next Age — Series A